NeuroVive receives research grant from Vinnova for development of the NVP015 genetic mitochondrial disease project
Lund, Sweden, 1 June 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company receives close to 1 million SEK in a research grant from Swedish innovati ...